8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
People assigned to a diet, food or program and measured.
2010 / 10-week clinical trial (control, controlled feeding, and self-selected phases)
Sixteen obese subjects completed a 10-week trial evaluating adaptations to alternate day modified fasting (ADMF), consisting of a 2-week control phase, 4-week controlled feeding phase, and 4-week self-selected feeding phase. Body weight decreased by 5.6 ± 1.0 kg post-treatment (P < 0.001). Energy intake on fast days was 26 ± 3% of baseline needs (501 ± 28 kcal/d), with no hyperphagic response on feed days (95 ± 6% consumed, 1801 ± 226 kcal/d). Fast-day hunger decreased by week 2 and remained low, while habitual physical activity was maintained throughout.
Klempel MC, Bhutani S, Fitzgibbon M, et al. Nutr J, 2010. PMID 20815899
2010 / Uncontrolled before-and-after trial
In 43 individuals (13 men, 30 women; aged 20-62 years) who completed a 21-day Daniel Fast, several health markers were lower post-fast than pre-fast (p < 0.05). These included total cholesterol (171.07 ± 4.57 vs. 138.69 ± 4.39 mg/dL), LDL cholesterol (98.38 ± 3.89 vs. 76.07 ± 3.53 mg/dL), HDL cholesterol (55.65 ± 2.50 vs. 47.58 ± 2.19 mg/dL), systolic blood pressure (114.65 ± 2.34 vs. 105.93 ± 2.12 mmHg), and diastolic blood pressure (72.23 ± 1.59 vs. 67.00 ± 1.43 mmHg). Caloric intake was also lower (2185 ± 94 vs. 1722 ± 85 kcal).
Bloomer RJ, Kabir MM, Canale RE, et al. Lipids Health Dis, 2010. PMID 20815907
2010 / Randomized controlled trial
In a 16-week randomized, double-blind, placebo-controlled trial, 46 patients with mild to moderate Alzheimer's disease received 30 mg daily of saffron or a placebo. Saffron produced significantly better cognitive outcomes than placebo on the ADAS-cog scale (P = 0.04) and clinical dementia rating (P = 0.04). No significant differences between groups were observed for adverse events.
Akhondzadeh S, Sabet MS, Harirchian MH, et al. J Clin Pharm Ther, 2010. PMID 20831681
2010 / Randomized controlled trial
Sixty postmenopausal women aged 40 to 60 were randomly assigned to daily soy supplementation containing 90 mg of isoflavones, low-dose hormone therapy, or placebo for 16 weeks. Somatic symptoms decreased by 49.8% with soy and 45.6% with hormone therapy, while urogenital symptoms improved by 31.2% and 38.6%, respectively. Neither overall symptom ratings nor psychological subscale scores differed significantly among the groups.
Carmignani LO, Pedro AO, Costa-Paiva LH, et al. Maturitas, 2010. PMID 20833488
2010 / Randomized controlled trial
Obese participants were randomly assigned to consume an isocaloric weight reduction diet for 12 weeks, with an afternoon snack of either 53 g of salted pistachios (n = 31) or 56 g of salted pretzels (n = 28). Both groups lost weight (p < 0.001), but changes in BMI differed significantly between the pistachio group (30.1 ± 0.4 to 28.8 ± 0.4) and pretzel group (30.9 ± 0.4 to 30.3 ± 0.5). Triglycerides were significantly lower in the pistachio group at 6 weeks (88.04 ± 9.80 vs. 144.56 ± 18.86 mg/dL, p = 0.01) and 12 weeks (88.10 ± 6.78 vs. 132.15 ± 16.76 mg/dL, p = 0.02). Total cholesterol, HDL, LDL, insulin, and glucose did not differ significantly between groups.
Li Z, Song R, Nguyen C, et al. J Am Coll Nutr, 2010. PMID 20833992
2010 / Randomized controlled trial
Healthy young men consumed a hyper-caloric (~+30% kcal/day), fat-rich (50% kcal) diet for 6 weeks while remaining sedentary (CON, n = 7), or undergoing endurance training 4 days/week either fasted (F, n = 10) or with carbohydrates consumed before and during exercise (CHO, n = 10). Body weight increased in CON (+3.0 ± 0.8 kg) and CHO (+1.4 ± 0.4 kg) (P < 0.01), but not in F (+0.7 ± 0.4 kg, P = 0.13). Compared with CON, training in the fasted state, but not CHO, improved whole-body glucose tolerance and Matsuda insulin sensitivity index (P < 0.05). Muscle GLUT4 protein content increased in F (+28%) compared with both CHO and CON, alongside elevated AMPKα phosphorylation and upregulated FAT/CD36 and CPT1 mRNA.
Van Proeyen K, Szlufcik K, Nielens H, et al. J Physiol, 2010. PMID 20837645
2010 / Randomized controlled trial
In a randomized trial, 168 older adults with mild cognitive impairment received daily B vitamins (0.8 mg folic acid, 0.5 mg B12, 20 mg B6) or placebo for 24 months. Brain atrophy averaged 0.76% per year in the active group versus 1.08% with placebo (P = 0.001). The response was greater among individuals with baseline homocysteine above 13 micromol/L, whose atrophy rate dropped by 53% (P = 0.001). Faster atrophy was linked to lower cognitive test scores.
Smith AD, Smith SM, de Jager CA, et al. PLoS One, 2010. PMID 20838622
2010 / Randomized controlled trial
In an 8-week clinical trial, 102 healthy male smokers were randomized to an antioxidant-rich diet, a diet supplemented with three kiwifruits daily, or a control group. Both dietary interventions significantly upregulated blood cell gene sets involved in cellular stress defense, including DNA repair, hypoxia, and apoptosis, relative to controls (FDR q < 0.05). Plasma antioxidant biomarkers also increased in both intervention arms.
Bøhn SK, Myhrstad MC, Thoresen M, et al. BMC Med, 2010. PMID 20846424
2010 / Randomized, placebo-controlled, double-blind trial
Fifty-eight patients with type 2 diabetes and HbA1c > 7% were randomized to receive either 2g of cinnamon or placebo daily for 12 weeks. Compared with placebo, the cinnamon group showed significant reductions in mean HbA1c (8.22% to 7.86% vs. 8.55% to 8.68%, P<0.005), systolic blood pressure (132.6 to 129.2 mmHg vs. 134.5 to 134.9 mmHg, P<0.001), and diastolic blood pressure (85.2 to 80.2 mmHg vs. 86.8 to 86.1 mmHg, P<0.001). Within the cinnamon group, fasting plasma glucose, waist circumference, and BMI decreased significantly from baseline, but differences were not significant compared to placebo. No significant differences were observed in serum lipid profiles between or within groups.
Akilen R, Tsiami A, Devendra D, et al. Diabet Med, 2010. PMID 20854384
2010 / Randomized 2-period crossover trial
Ten overweight nonsmoking adults underwent two 14-day periods of moderate caloric restriction with either 8.5 or 5.5 hours of nighttime sleep opportunity. Sleep curtailment reduced fat loss by 55% (1.4 vs. 0.6 kg; P = 0.043) and increased the loss of fat-free body mass by 60% (1.5 vs. 2.4 kg; P = 0.002). It was also accompanied by markers of enhanced neuroendocrine adaptation to caloric restriction, increased hunger, and a shift toward oxidizing less fat. The study was limited by its duration and small sample size.
Nedeltcheva AV, Kilkus JM, Imperial J, et al. Ann Intern Med, 2010. PMID 20921542
2010 / Randomized crossover clinical trial
A randomized crossover study in 30 healthy subjects evaluated the bioavailability of acetate from 9 vinegar capsules (750 mg acetic acid total), 100 mL of vinegar drink (750 mg acetic acid), and 150 mL of water as reference after an overnight fast. Serum acetate peaked at 15 min with the drink and returned to baseline at 90 min, while it peaked at 30 min with capsules and returned to baseline at 120 min; peak values in both groups exceeded 200 µmol/L. The absorbed acetate area under the curve for capsules (AUC(capsule-ref)) was about 80% of that for the drink (AUC(drink-ref)), with no significant difference between them.
Sugiyama S, Fushimi T, Kishi M, et al. J Nutr Sci Vitaminol (Tokyo), 2010. PMID 20924150
2010 / Double-blind, multicenter, randomized controlled trial
In the DOMInO trial, 2399 pregnant women were randomized to receive 800 mg/d DHA via fish oil capsules or matched vegetable oil capsules without DHA until birth. High postpartum depressive symptoms occurred in 9.67% of women in the DHA group and 11.19% in the control group (adjusted RR, 0.85; 95% CI, 0.70-1.02; P = .09). Among children followed at 18 months, mean cognitive composite scores (adjusted mean difference, 0.01; 95% CI, -1.36 to 1.37; P = .99) and mean language composite scores (adjusted mean difference, -1.42; 95% CI, -3.07 to 0.22; P = .09) did not differ significantly between groups.
Makrides M, Gibson RA, McPhee AJ, et al. JAMA, 2010. PMID 20959577
2010 / Double-blind randomized controlled trial
Forty-nine resistance-trained men were randomized to ingest capsules containing 500 mg of fenugreek extract (N = 26) or placebo (N = 23) over an 8-week supervised resistance-training program. Significant group by time interaction effects favored fenugreek for body fat change (-2.3 ± 1.4% vs. -0.39 ± 1.6%, p < 0.001), leg press 1-RM increase (84.6 ± 36.2 kg vs. 48 ± 29.5 kg, p < 0.001), and bench press 1-RM increase (9.1 ± 6.9 kg vs. 4.3 ± 5.6 kg, p = 0.01). No significant interactions were observed for Wingate power analysis, muscular endurance, or clinical safety panels.
Poole C, Bushey B, Foster C, et al. J Int Soc Sports Nutr, 2010. PMID 20979623
2010 / Randomized controlled crossover trial
In a randomized controlled crossover study, 17 men diagnosed with prostate cancer consumed 485 g of rye whole grain and bran products (RP) or refined wheat products with added cellulose (WP) (~50% of daily energy intake). Plasma total PSA concentrations were lower after RP compared with WP, showing a mean treatment effect of -14% (P = 0.04). Fasting plasma insulin and 24-h urinary C-peptide excretion were also lower after RP compared with WP (P < 0.01 and P = 0.01, respectively), while daily excretion of 5 lignans was higher (P < 0.001).
Landberg R, Andersson SO, Zhang JX, et al. J Nutr, 2010. PMID 20980650
2010 / Double-blind, cross-over trial
In a double-blind, cross-over trial, 27 participants ingested 2 g of ginger or placebo at 24 h and 48 h after eccentric exercise. Overall, ginger had no effect compared with placebo on muscle pain, dysfunction, or metabolic rate 45 minutes after ingestion. In a subset consuming ginger 24 h post-exercise, arm pain was reduced the following day (13%, -5.9 ± 8.8 mm), whereas placebo ingestion showed no change (0.0 ± 14.7 mm).
Black CD, O'Connor PJ Phytother Res, 2010. PMID 21031618
2010 / Randomized crossover trial
In 12 healthy subjects, researchers tested the effects of consuming 1 L of clear apple juice, polyphenol-free clear apple juice, cloudy apple juice, or water across sessions separated by 4-day intervals. All three juices transiently raised FRAP and serum DPPH radical-scavenging activity, peaking at 1 hour post-ingestion. This rise paralleled an increase in serum uric acid, while plasma total phenolics and quercetin showed no significant changes. Strong significant correlations appeared between serum uric acid and plasma antioxidant activity across all time points, indicating that fructose-induced uric acid, rather than polyphenols, accounted for the increased antioxidant capacity.
Godycki-Cwirko M, Krol M, Krol B, et al. J Am Coll Nutr, 2010. PMID 21041815
2010 / Randomized crossover trial
In a double-blind, randomized crossover trial, 16 healthy adults (mean age 25 ± 5 years) received 1,200 mg of oral aloe vera powder or placebo. Maximum post-treatment Q-Tc intervals were 422 ± 17 milliseconds with aloe vera and 419 ± 17 milliseconds with placebo, with no significant differences between groups across an 8-hour monitoring period. Similarly, no significant differences appeared in P-R intervals, QRS duration, or systolic and diastolic blood pressure.
Shah SA, DiTullio P, Azadi M, et al. Am J Health Syst Pharm, 2010. PMID 21048211
2010 / Interventional follow-up study
This study evaluated adjunctive treatment with Norflo tablets (curcumin-phosphatidylcholine complex; Meriva) given twice daily for 12 months in 106 patients with recurrent anterior uveitis categorized into three etiological groups. The primary endpoint of relapse frequency showed a statistically significant reduction before versus after treatment across all groups (P < 0.001). Additionally, the treatment was well tolerated and reduced eye discomfort signs and symptoms after a few weeks in more than 80% of patients.
Allegri P, Mastromarino A, Neri P Clin Ophthalmol, 2010. PMID 21060672
2010 / Randomized controlled trial
A randomized controlled trial evaluated 230 infants with genetic susceptibility to type 1 diabetes who received either casein hydrolysate or standard cow's-milk-based formula when breast milk was unavailable during the first 6 to 8 months of life. Over a median 10-year follow-up, infants assigned to casein hydrolysate had a lower risk of developing one or more autoantibodies (unadjusted HR 0.54; 95% CI, 0.29 to 0.95; adjusted HR 0.51; 95% CI, 0.28 to 0.91). Positivity for two or more autoantibodies did not differ significantly between groups.
Knip M, Virtanen SM, Seppä K, et al. N Engl J Med, 2010. PMID 21067382
2010 / Before-after clinical trial
In an uncontrolled trial of 30 men with mild hyperlipidemia, eating 60 g of almonds daily for 4 weeks significantly reduced total cholesterol, low-density lipoprotein cholesterol, and apolipoprotein B100. Supplementation also altered the correlation structure between lipid risk markers and copper-induced lipid oxidation parameters. Baseline showed little association, whereas post-supplementation total cholesterol correlated positively with oxidation lag-time (r = 0.6, p = 0.001) and negatively with maximal oxidation rate.
Jalali-Khanabadi BA, Mozaffari-Khosravi H, Parsaeyan N J Altern Complement Med, 2010. PMID 21114415
2010 / Comparative in vitro and human mastication study
Researchers examined the effect of mechanical breakdown and thermal processing on carrot all-E-β-carotene bioaccessibility, and tested human mastication of raw, gently cooked, and intensely cooked carrots in 15 individuals to model in vitro mastication. All-E-β-carotene bioaccessibility was strongly dependent on particle size for raw and gently cooked carrots, whereas after intense cooking, considerable amounts were released from both cell fragments and cell clusters. The average particle size distribution from the 15 participants was successfully mimicked by mixing 50 g of carrots in a Grindomix at 2500 rpm for 5 seconds.
Lemmens L, Van Buggenhout S, Van Loey AM, et al. J Agric Food Chem, 2010. PMID 21121612
2010 / Controlled dietary intervention trial
This 6-week, three-phase study assessed the effect of eating two Hayward green kiwifruits daily for 4 weeks compared to two placebo capsules daily in patients with IBS/C (41 kiwifruit, 13 placebo) along with 16 healthy adults consuming kiwifruit. After the 4-week intervention, weekly defecation frequency significantly increased (p<0.05) and colon transit time significantly decreased (p=0.026) in IBS/C participants who consumed kiwifruit. The findings suggest that consuming kiwifruit for 4 weeks shortens colon transit time and improves bowel function in adults with IBS/C.
Chang CC, Lin YT, Lu YT, et al. Asia Pac J Clin Nutr, 2010. PMID 21147704
2010 / Controlled clinical trial
An eight-month controlled study evaluated the efficacy and safety of Meriva, a curcumin-phosphatidylcholine complex, in 100 osteoarthritis patients. Significant improvements in both clinical endpoints (WOMAC score, Karnofsky Performance Scale Index, and treadmill walking performance) and biochemical endpoints (IL-1beta, IL-6, sCD40L, sVCAM-1, and ESR) were observed for Meriva compared to the control group. The authors reported excellent tolerability.
Belcaro G, Cesarone MR, Dugall M, et al. Altern Med Rev, 2010. PMID 21194249
2010 / Human consumption study with in vitro experiments
Researchers evaluated the antioxidant properties of balsamic vinegar in human volunteers and in cultured macrophages. Following intake by human participants, the vinegar prolonged the oxidation lag time of low-density lipoprotein while lowering lipid peroxide and lyso-phosphatidylcholine contents. Laboratory assays also demonstrated that balsamic vinegar diminished scavenger receptor expression and restricted foam cell development in THP-1 cells.
Iizuka M, Tani M, Kishimoto Y, et al. J Nutr Sci Vitaminol (Tokyo), 2010. PMID 21422711